close
close

Call for papers – Respiratory viruses: surveillance, diagnostics and emergence

Genome medicine invites submissions for a new collection on the surveillance, diagnostics, and emergence of respiratory viruses. Topics include viral surveillance and genomics, host-pathogen interactions and immune escape, and diagnostics, treatment, and vaccine development.

The COVID-19 pandemic and the recent re-emergence of avian influenza A(H5N1) have brought the importance of respiratory viruses into global focus. Respiratory viruses remain a threat to public health and research on emerging and re-emerging respiratory viruses remains a high priority. This collection calls for papers to advance our understanding of respiratory virus infections, insights into viral genomics, host-pathogen interactions, immune response and escape, interspecies transmission as emerging human infections, and the development of novel diagnostics, treatments and vaccines. Submitted research will illuminate the interface between genomic medicine and viruses and will span areas as diverse as viral genomics, vaccine development and the molecular basis of viral pathogenesis.

New research in this field is critical for developing targeted interventions against viral infections and understanding the molecular mechanisms underlying viral pathogenesis. Recent advances have highlighted the importance of genomic diversity of respiratory viruses across a range of hosts, facilitated the development of diagnostic tools and vaccines, and contributed to the prediction of emerging human pathogenic respiratory viruses.

We now invite submissions of manuscripts on research, methods, software, databases and guidelines, including the following topics:

  • Viral genomics and evolution
  • Surveillance and pandemic preparedness for emerging and re-emerging respiratory viruses
  • Host-pathogen interactions
  • Host change for emerging viruses
  • Immune reactions and immune evasion
  • Long-term consequences of viral infections
  • Novel diagnostic technologies
  • New antiviral treatments
  • Vaccine development

Photo credit: © [M] Dr_Microbe / Stock.adobe.com